Id |
Subject |
Object |
Predicate |
Lexical cue |
T141 |
0-140 |
Sentence |
denotes |
In addition to chemerin, RvE1 was identified as a second endogenous agonist through a screening program against the GPCR panel (Arita et al. |
T142 |
141-147 |
Sentence |
denotes |
2007). |
T143 |
148-316 |
Sentence |
denotes |
ERV1 (chemokine like receptor 1, also known as CMKLR1) is a receptor for RvE1, which has been shown to bind more strongly than chemerin (a peptide ligand) (Arita et al. |
T144 |
317-338 |
Sentence |
denotes |
2005; Wittamer et al. |
T145 |
339-345 |
Sentence |
denotes |
2004). |
T146 |
346-501 |
Sentence |
denotes |
ERV1 overexpressing mice showed a large increase in phagocytosis upon decreased neutrophil inhibition and decreased neutrophil infiltration (Herrera et al. |
T147 |
502-508 |
Sentence |
denotes |
2015). |
T148 |
509-611 |
Sentence |
denotes |
Also, RvE2 is a partial agonist compared to RvE1 in CHO-chemerin1 β-arrestin recruitment (Isobe et al. |
T149 |
612-619 |
Sentence |
denotes |
2012a). |
T150 |
620-755 |
Sentence |
denotes |
However, since there is no additional information on this ligand, further investigation of potential ligand-receptor pairs is required. |